ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis

Cell Reports

Volumn 10, Issue 6, 2015, Pages 957-967

  Takagi, Masatoshi ^a   Uno, Hatsume ^a,b   Nishi, Rina ^a   Sugimoto, Masataka ^c   Hasegawa, Setsuko ^a   Piao, Jinhua ^a   Ihara, Norimasa ^d   Kanai, Sayaka ^e   Kakei, Saori ^f   Tamura, Yoshifumi ^f   Suganami, Takayoshi ^e   Kamei, Yasutomi ^g   Shimizu, Toshiaki ^h   Yasuda, Akio ^c   Ogawa, Yoshihiro ^e   Mizutani, Shuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SONY CORPORATION   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYOTO PREFECTURAL UNIVERSITY   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ATM PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; E1A ASSOCIATED P300 PROTEIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL CYCLE REGULATION; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

MUS;

EID: 84923114348     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.01.027     Document Type: Article

References (61)

1. Abella A., Dubus P., Malumbres M., Rane S.G., Kiyokawa H., Sicard A., Vignon F., Langin D., Barbacid M., Fajas L. Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab. 2005, 2:239-249.
2. Akagiri S., Naito Y., Ichikawa H., Mizushima K., Takagi T., Handa O., Kokura S., Yoshikawa T. A mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice. J.Clin. Biochem. Nutr. 2008, 42:150-157.
3. Armata H.L., Golebiowski D., Jung D.Y., Ko H.J., Kim J.K., Sluss H.K. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol. Cell. Biol. 2010, 30:5787-5794.
4. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
5. Bar R.S., Levis W.R., Rechler M.M., Harrison L.C., Siebert C., Podskalny J., Roth J., Muggeo M. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N.Engl. J. Med. 1978, 298:1164-1171.
6. Bensimon A., Schmidt A., Ziv Y., Elkon R., Wang S.Y., Chen D.J., Aebersold R., Shiloh Y. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci. Signal. 2010, 3:rs3.
7. Berkovich E., Monnat R.J., Kastan M.B. Assessment of protein dynamics and DNA repair following generation of DNA double-strand breaks at defined genomic sites. Nat. Protoc. 2008, 3:915-922.
8. Blevins L.S., Gebhart S.S. Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia. South. Med. J. 1996, 89:619-621.
9. Fajas L., Landsberg R.L., Huss-Garcia Y., Sardet C., Lees J.A., Auwerx J. E2Fs regulate adipocyte differentiation. Dev. Cell 2002, 3:39-49.
10. Fernandes N.D., Sun Y., Price B.D. Activation of the kinase activity of ATM by retinoic acid is required for CREB-dependent differentiation of neuroblastoma cells. J.Biol. Chem. 2007, 282:16577-16584.
11. Florez J.C., Jablonski K.A., Taylor A., Mather K., Horton E., White N.H., Barrett-Connor E., Knowler W.C., Shuldiner A.R., Pollin T.I. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program. Diabetes Care 2012, 35:1864-1867. Diabetes Prevention Program Research Group.
12. Gavrilova O., Marcus-Samuels B., Graham D., Kim J.K., Shulman G.I., Castle A.L., Vinson C., Eckhaus M., Reitman M.L. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J.Clin. Invest. 2000, 105:271-278.
13. Herzog K.H., Chong M.J., Kapsetaki M., Morgan J.I., McKinnon P.J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998, 280:1089-1091.
14. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
15. Iwahori S., Yasui Y., Kudoh A., Sato Y., Nakayama S., Murata T., Isomura H., Tsurumi T. Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites. Cell. Signal. 2008, 20:1795-1803.
16. Jang E.R., Choi J.D., Jeong G., Lee J.S. Phosphorylation of p300 by ATM controls the stability of NBS1. Biochem. Biophys. Res. Commun. 2010, 397:637-643.
17. Ju B.G., Lunyak V.V., Perissi V., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 2006, 312:1798-1802.
18. Kamijo T., van de Kamp E., Chong M.J., Zindy F., Diehl J.A., Sherr C.J., McKinnon P.J. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res. 1999, 59:2464-2469.
19. Kim J., Wong P.K. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cells 2009, 27:1987-1998.
20. Kita Y., Takamura T., Misu H., Ota T., Kurita S., Takeshita Y., Uno M., Matsuzawa-Nagata N., Kato K., Ando H., et al. Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PLoS ONE 2012, 7:e43056.
21. Lin W.C., Lin F.T., Nevins J.R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 2001, 15:1833-1844.
22. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
23. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580:2917-2921.
24. McFarlin D.E., Strober W., Waldmann T.A. Ataxia-telangiectasia. Medicine (Baltimore) 1972, 51:281-314.
25. Miles P.D., Treuner K., Latronica M., Olefsky J.M., Barlow C. Impaired insulin secretion in a mouse model of ataxia telangiectasia. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E70-E74.
26. Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 2009, 15:1082-1087.
27. Morio T., Takahashi N., Watanabe F., Honda F., Sato M., Takagi M., Imadome K., Miyawaki T., Delia D., Nakamura K., et al. Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan. Int. J. Hematol. 2009, 90:455-462.
28. Morrell D., Chase C.L., Kupper L.L., Swift M. Diabetes mellitus in ataxia-telangiectasia, Fanconi anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes 1986, 35:143-147.
29. Palmer N.D., Langefeld C.D., Campbell J.K., Williams A.H., Saad M., Norris J.M., Haffner S.M., Rotter J.I., Wagenknecht L.E., Bergman R.N., et al. Genetic mapping of disposition index and acute insulin response loci on chromosome 11q. The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2006, 55:911-918.
30. Park B.H., Qiang L., Farmer S.R. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol. Cell. Biol. 2004, 24:8671-8680.
31. Peretz S., Jensen R., Baserga R., Glazer P.M. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc. Natl. Acad. Sci. USA 2001, 98:1676-1681.
32. Prieur X., Dollet L., Takahashi M., Nemani M., Pillot B., Le May C., Mounier C., Takigawa-Imamura H., Zelenika D., Matsuda F., et al. Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice. Diabetologia 2013, 56:1813-1825.
33. Raman M., Earnest S., Zhang K., Zhao Y., Cobb M.H. TAO kinases mediate activation of p38 in response to DNA damage. EMBO J. 2007, 26:2005-2014.
34. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., Russell R.G., Li M., Tang B., Jelicks L.A., Scherer P.E., Lisanti M.P. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J.Biol. Chem. 2002, 277:8635-8647.
35. Rodeheffer M.S., Birsoy K., Friedman J.M. Identification of white adipocyte progenitor cells invivo. Cell 2008, 135:240-249.
36. Rosen E.D., Spiegelman B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 2000, 16:145-171.
37. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
38. Safrin S., Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999, 13:2493-2505.
39. Schalch D.S., McFarlin D.E., Barlow M.H. An unusual form of diabetes mellitus in ataxia telangiectasia. N.Engl. J. Med. 1970, 282:1396-1402.
40. Schneider J.G., Finck B.N., Ren J., Standley K.N., Takagi M., Maclean K.H., Bernal-Mizrachi C., Muslin A.J., Kastan M.B., Semenkovich C.F. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 2006, 4:377-389.
41. Schubert R., Reichenbach J., Zielen S. Growth factor deficiency in patients with ataxia telangiectasia. Clin. Exp. Immunol. 2005, 140:517-519.
42. Schwartz C., Beck K., Mink S., Schmolke M., Budde B., Wenning D., Klempnauer K.H. Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity. EMBO J. 2003, 22:882-892.
43. Shahrabani-Gargir L., Pandita T.K., Werner H. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1. Endocrinology 2004, 145:5679-5687.
44. Shi Y., Venkataraman S.L., Dodson G.E., Mabb A.M., LeBlanc S., Tibbetts R.S. Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proc. Natl. Acad. Sci. USA 2004, 101:5898-5903.
45. Storozhuk Y., Hopmans S.N., Sanli T., Barron C., Tsiani E., Cutz J.C., Pond G., Wright J., Singh G., Tsakiridis T. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br. J. Cancer 2013, 108:2021-2032.
46. Su Y., Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann. Intern. Med. 2000, 133:770-778.
47. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 1997, 16:7432-7443.
48. Tang Q.Q., Jiang M.S., Lane M.D. Repression of transcription mediated by dual elements in the CCAAT/enhancer binding protein alpha gene. Proc. Natl. Acad. Sci. USA 1997, 94:13571-13575.
49. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., Ingram A.J. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J.Biol. Chem. 2002, 277:12710-12717.
50. Tang Q.Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:44-49.
51. Tang Q.Q., Zhang J.W., Daniel Lane M. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem. Biophys. Res. Commun. 2004, 318:213-218.
52. Valentin-Vega Y.A., Maclean K.H., Tait-Mulder J., Milasta S., Steeves M., Dorsey F.C., Cleveland J.L., Green D.R., Kastan M.B. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119:1490-1500.
53. Vazquez-Martin A., Oliveras-Ferraros C., Cufí S., Martin-Castillo B., Menendez J.A. Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response. Cell Cycle 2011, 10:1499-1501.
54. Walker U.A., Brinkman K. An argument for mitochondrial toxicity in highly active antiretroviral therapy-induced lipoatrophy. AIDS 2001, 15:1450-1452.
55. Wang H., Larris B., Peiris T.H., Zhang L., Le Lay J., Gao Y., Greenbaum L.E. C/EBPbeta activates E2F-regulated genes invivo via recruitment of the coactivator CREB-binding protein/P300. J.Biol. Chem. 2007, 282:24679-24688.
56. Wong R.H., Chang I., Hudak C.S., Hyun S., Kwan H.Y., Sul H.S. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell 2009, 136:1056-1072.
57. Woods A., Leiper J.M., Carling D. The role of ATM in response to metformin treatment and activation of AMPK. Nat. Genet. 2012, 44:360-361.
58. Yang D.Q., Kastan M.B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2000, 2:893-898.
59. Yee S.W., Chen L., Giacomini K.M. The role of ATM in response to metformin treatment and activation of AMPK. Nat. Genet. 2012, 44:359-360.
60. Zhang J.W., Klemm D.J., Vinson C., Lane M.D. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J.Biol. Chem. 2004, 279:4471-4478.
61. Zhou K., Bellenguez C., Spencer C.C., Bennett A.J., Coleman R.L., Tavendale R., Hawley S.A., Donnelly L.A., Schofield C., Groves C.J., et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat. Genet. 2011, 43:117-120. GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2, MAGIC investigatorsMAGIC investigators.